EFFECT OF HYDROXYPROPYL-β-CYCLODEXTRIN ON THE SOLUBILITY, STABILITY AND IN-VITRO RELEASE OF CIPROFLOXACIN FOR OCULAR DRUG DELIVERY

被引:0
作者
Bozkir, Asuman [1 ]
Denli, Zeynep Fusun [2 ]
Basaran, Berrin [1 ]
机构
[1] Ankara Univ, Fac Pharm, Dept Pharmaceut Technol, TR-06100 Ankara, Turkey
[2] Turkish Stand Inst, TR-06100 Ankara, Turkey
来源
ACTA POLONIAE PHARMACEUTICA | 2012年 / 69卷 / 04期
关键词
ciprofloxacin; hydroxypropyl-beta-cyclodextrin; ophthalmic solution; solubility; stability; WATER-SOLUBLE POLYMERS; OPHTHALMIC FORMULATIONS; CORNEAL PERMEABILITY; AQUEOUS SOLUBILITY; DEXAMETHASONE; 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN; COMPLEXATION; EYE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Eye drops in the form of an aqueous solution with a lower viscosity are preferred for local administrations in ophthalmology. In ophthalmic formulations, cyclodextrins (CDs) are frequently used in recent years in order to increase water solubility, stability and bioavailability of an active substance and decrease an irritation to the eye. The scope of the present study was to investigate the influence of hydroxypropyl-beta-cyclodextrin (HPCD) on the solubility, stability and in vino release of ciprofloxacin (CIP). According to the phase solubility studies, A, type solubility curve was obtained. HPCD improved the solubility of CIP 3 times at pH 5.5 and 2 times at pH 7.4. The two month stability studies indicated that CIP was more stable at pH 5.5 than at pH 7.4 and the stability of CIP was significantly increased by HPCD. The stability constant of the HPCD:CIP complex was increased further by addition of 0.1% (w/v) polymer (HPMC and PVP) to the aqueous medium including HPCD. Stability constant of solutions prepared in an ultrasonic water bath was higher than solutions prepared by heating in an autoclave. The results indicated that the CIP:HPCD complex increased in vino release of CIP and the addition of polymer promoted this increase even more.
引用
收藏
页码:719 / 724
页数:6
相关论文
共 32 条
  • [1] Gels and liposomes in optimized ocular drug delivery:: Studies on ciprofloxacin formulations
    Budai, Livia
    Hajdu, Maria
    Budai, Marianna
    Grof, Pal
    Beni, Szabolcs
    Noszal, Bela
    Klebovich, Imre
    Antal, Istvan
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 343 (1-2) : 34 - 40
  • [2] Solubilization of tropicamide by hydroxypropyl-β-cyclodextrin and water-soluble polymers:: in vitro/in vivo studies
    Cappello, B
    Carmignani, C
    Iervolino, M
    La Rotonda, MI
    Saettone, MF
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 213 (1-2) : 75 - 81
  • [3] Preparation and study on the novel solid inclusion complex of ciprofloxacin with HP-β-cyclodextrin
    Chao, JB
    Meng, DP
    Li, JS
    Xu, H
    Huang, SP
    [J]. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2004, 60 (03) : 729 - 734
  • [4] Evaluation of a hydrocortisone/hydroxypropyl-beta-cyclodextrin solution for ocular drug delivery
    Davies, NM
    Wang, GJ
    Tucker, IG
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 156 (02) : 201 - 209
  • [5] Cyclodextrins and their uses: a review
    Del Valle, EMM
    [J]. PROCESS BIOCHEMISTRY, 2004, 39 (09) : 1033 - 1046
  • [6] Dorne HV, 1993, EUR J PHARM BIOPHARM, V39, P133
  • [7] Duschene D, 1990, PHARM TECHNOL, V14, P26
  • [8] Granero G, 2002, Boll Chim Farm, V141, P63
  • [9] Higuchi T., 1965, Adv. Anal. Chem. Instrum., V4, P117, DOI DOI 10.1016/S0076-6879(82)87029-8
  • [10] Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: Formulation of dorzolamide eye drop microparticle suspension
    Jansook, Phatsawee
    Stefansson, Einar
    Thorsteinsdottir, Margret
    Sigurdsson, Baldur B.
    Kristjansdottir, Sigrun S.
    Bas, Jon Fernandez
    Sigurdsson, Hakon H.
    Loftsson, Thorsteinn
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2010, 76 (02) : 208 - 214